JNJ vs BSX
By Alex · Tickerpine
Johnson & Johnson vs Boston Scientific Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | BSX |
|---|---|---|
| Price | $254.66 | $44.23 |
| Market cap | $613.02B | $65.74B |
| P/E ratio | 29.5 | 18.5 |
| ROE | 26.42% | 14.66% |
| Profit margin | 21.83% | 17.29% |
| Revenue growth | 9.90% | 11.60% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 0.56 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs BSX in plain English
- JNJ is the bigger company — about 9.3× the market cap of BSX.
- BSX is cheaper on earnings (P/E 18.5 vs 29.5).
- JNJ earns a higher return on equity (26% vs 15%).
- BSX is growing revenue faster (12% vs 10%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
BSX return calculator
See what $1,000 in Boston Scientific Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.